A history of the role of the hERG channel in cardiac risk assessment
- 26 March 2013
- journal article
- Published by Elsevier BV in Journal of Pharmacological and Toxicological Methods
- Vol. 68 (1), 13-22
- https://doi.org/10.1016/j.vascn.2013.03.005
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Molecular Determinants of Pentamidine-Induced hERG Trafficking InhibitionMolecular Pharmacology, 2011
- Antidepressant-induced Ubiquitination and Degradation of the Cardiac Potassium Channel hERGJournal of Biological Chemistry, 2011
- Progesterone Impairs Human Ether-a-go-go-related Gene (HERG) Trafficking by Disruption of Intracellular Cholesterol HomeostasisPublished by Elsevier BV ,2011
- Integrated risk assessment and predictive value to humans of non‐clinical repolarization assaysBritish Journal of Pharmacology, 2010
- Drug‐induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectivesBritish Journal of Pharmacology, 2010
- HERG1 channelopathiesPflügers Archiv - European Journal of Physiology, 2009
- Principles of Safety PharmacologyBritish Journal of Pharmacology, 2008
- Coexistence of hERG current block and disruption of protein trafficking in ketoconazole‐induced long QT syndromeBritish Journal of Pharmacology, 2008
- Drug‐induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetineBritish Journal of Pharmacology, 2006
- Crystal structure and mechanism of a calcium-gated potassium channelNature, 2002